IM Cannabis Corp (IMCC)
NASDAQ:IMCC
Want to see IMCC full AI Analyst Report?
IMCC Stock Chart & Stats
$1.44
-$0.13(-4.96%)
At close: 4:00 PM EST
$1.44
-$0.13(-4.96%)
Day’s Range― - ―
52-Week Range$0.30 - $7.12
Previous Close$2.49
Volume28.72K
Average Volume (3M)72.27K
Market Cap
$2.38M
Enterprise Value$32.03M
Total Cash (Recent Filing)$2.73M
Total Debt (Recent Filing)$16.27M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.93
Shares Outstanding6,223,323
10 Day Avg. Volume74,089
30 Day Avg. Volume72,265
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-9.42
Price to Sales (P/S)0.15
P/FCF Ratio1.72
Enterprise Value/Market Cap13.45
Enterprise Value/Revenue0.59
Enterprise Value/Gross Profit3.31
Enterprise Value/Ebitda-4.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$62.75M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue ScaleMeaningful multi-year top-line expansion shows the company has scaled its commercial footprint and product distribution. Larger revenue base improves ability to cover fixed costs, supports investment in operations and R&D, and makes future margin improvements more impactful to cash generation.
Cash Flow TurnaroundA material swing to positive operating and free cash flow demonstrates improving cash generation and internal funding capacity. Durable cash flow would reduce reliance on external funding, support working capital and capex, and signal progress toward self-sustaining operations if maintained.
Strong German Market Position & Regulatory Cert.Rapid German sales growth and an EU‑GMP certified platform provide a structural competitive advantage in Europe. Regulatory certification and scale in a legalizing market create barriers to entry, enhance credibility with healthcare channels, and anchor a durable revenue stream.
Bears Say
Deteriorated Balance Sheet / Negative EquityNegative equity and a shrinking asset base materially weaken financial flexibility. Debt-to-equity is effectively meaningless, creditor and covenant risk rises, and the company has less capacity to absorb shocks or fund growth without dilutive or expensive financing.
Persistent UnprofitabilityDespite revenue growth, consistently negative operating and net margins indicate the business has not yet achieved sustainable profitability. Low gross margins (~16–20%) and ongoing losses imply continued pressure on cash flow unless structural cost or pricing improvements occur.
Reliance On Equity‑Linked FinancingRepeated convertible note and warrant financings signal dependence on equity-linked capital, exposing shareholders to dilution and the company to refinancing risk. Such financing often reflects constrained access to cheaper debt and can limit strategic optionality over the medium term.
IM Cannabis Corp News
IMCC FAQ
What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $0.29 and its highest was $7.12 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $2.38M.
When is IM Cannabis Corp’s upcoming earnings report date?
IM Cannabis Corp’s upcoming earnings report date is May 18, 2026 which is in 32 days.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on Mar 30, 2026. The company reported -$0.929 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.929.
Is IM Cannabis Corp overvalued?
According to Wall Street analysts IM Cannabis Corp’s price is currently Overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 6,223,323 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$0.929 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.314%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IM Cannabis Corp
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Technical Analysis
Ownership Overview
54.57% Insiders
3.15% Other Institutional Investors
42.28% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---